These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1976080)

  • 21. Catalytic mechanism of limonene epoxide hydrolase, a theoretical study.
    Hopmann KH; Hallberg BM; Himo F
    J Am Chem Soc; 2005 Oct; 127(41):14339-47. PubMed ID: 16218628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of potent inhibitors of the human microsomal epoxide hydrolase.
    Barnych B; Singh N; Negrel S; Zhang Y; Magis D; Roux C; Hua X; Ding Z; Morisseau C; Tantillo DJ; Siegel JB; Hammock BD
    Eur J Med Chem; 2020 May; 193():112206. PubMed ID: 32203787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of valproic acid on the disposition of carbamazepine and carbamazepine-10,11-epoxide in the rat.
    Chang SL; Levy RH
    Drug Metab Dispos; 1986; 14(3):281-6. PubMed ID: 2872025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insights into human microsomal epoxide hydrolase by combined homology modeling, molecular dynamics simulations, and molecular docking calculations.
    Saenz-Méndez P; Katz A; Pérez-Kempner ML; Ventura ON; Vázquez M
    Proteins; 2017 Apr; 85(4):720-730. PubMed ID: 28120429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective and regioselective hydration of 7-methylbenz[c]acridine-5,6-oxide enantiomers by rodent and human microsomal epoxide hydrolases.
    Roberts-Thomson SJ; McManus ME; Duke CC; Agnew R; Holder GM
    Mol Pharmacol; 1996 Jan; 49(1):105-11. PubMed ID: 8569695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of microsomal epoxide hydrolases by ureas, amides, and amines.
    Morisseau C; Newman JW; Dowdy DL; Goodrow MH; Hammock BD
    Chem Res Toxicol; 2001 Apr; 14(4):409-15. PubMed ID: 11304129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
    Pacifici GM; Temellini A; Giuliani L; Rane A; Thomas H; Oesch F
    Arch Toxicol; 1989; 63(2):157-9. PubMed ID: 2499297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Taylor SJ; Muegge I; Farrow NA; Joseph D; McKellop K; Man CC; Kukulka A; De Lombaert S
    J Med Chem; 2009 Oct; 52(19):5880-95. PubMed ID: 19746975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of microsomal-membrane bound and purified epoxide hydrolase by C2-C8 1,2-alkene oxides.
    Dent JG; Schnell SR
    Biochem Pharmacol; 1981 Jun; 30(12):1712-4. PubMed ID: 7271858
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic microsomal cholesterol epoxide hydrolase: selective inhibition by detergents and separation from xenobiotic epoxide hydrolase.
    Watabe T; Ozawa N; Ishii H; Chiba K; Hiratsuka A
    Biochem Biophys Res Commun; 1986 Oct; 140(2):632-7. PubMed ID: 3778472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of valpromide and viloxazine on the elimination of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Perucca E; Pisani F; Spina E; Oteri G; Fazio A; Bertilsson L
    Pharmacol Res; 1989; 21(1):111-2. PubMed ID: 2498859
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of in vivo microsomal epoxide hydrolase activity in white subjects.
    Kroetz DL; Kerr BM; McFarland LV; Loiseau P; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1993 Mar; 53(3):306-15. PubMed ID: 8453849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleotide and deduced amino acid sequence of human liver microsomal epoxide hydrolase.
    Jackson MR; Craft JA; Burchell B
    Nucleic Acids Res; 1987 Sep; 15(17):7188. PubMed ID: 3502697
    [No Abstract]   [Full Text] [Related]  

  • 34. Regioselectivity in enzymatic hydration of cis-1,2-disubstituted [18O]-expoxides.
    Hanzlik RP; Heideman S; Smith D
    Biochem Biophys Res Commun; 1978 May; 82(1):310-5. PubMed ID: 666904
    [No Abstract]   [Full Text] [Related]  

  • 35. Investigation in the dipropylacetic acid series, C8 and C9 branched chain ethylenic acids and amides.
    Taillandier G; Benoit-Guyod JL; Laruelle C; Boucherle A
    Arch Pharm (Weinheim); 1977 May; 310(5):394-403. PubMed ID: 326226
    [No Abstract]   [Full Text] [Related]  

  • 36. Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.
    Spiegelstein O; Yagen B; Levy RH; Finnell RH; Bennett GD; Roeder M; Schurig V; Bialer M
    Pharm Res; 1999 Oct; 16(10):1582-8. PubMed ID: 10554101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unsubstituted amides: new class of potent inhibitors of human microsomal epoxide hydrolase.
    Kerr BM; Levy RH
    Drug Metab Dispos; 1990; 18(4):540-2. PubMed ID: 1976080
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
    Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Spiegelstein O; Kroetz DL; Levy RH; Yagen B; Hurst SI; Levi M; Haj-Yehia A; Bialer M
    Pharm Res; 2000 Feb; 17(2):216-21. PubMed ID: 10751038
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.